HomeMarket NewsAmdocs (DOX) Q2 Earnings Miss Estimates, Revenues Match

Amdocs (DOX) Q2 Earnings Miss Estimates, Revenues Match

Actionable Trade Ideas

always free

Amdocs Limited DOX reported second-quarter fiscal 2024 results, wherein earnings missed the Zacks Consensus Estimate and revenues matched the same. However, both the top and bottom lines marked a year-over-year improvement.

The company reported second-quarter non-GAAP earnings of $1.56 per share, missing the consensus mark of $1.58. The non-GAAP earnings per share matched the midpoint of management’s guidance of $1.53-$1.59. Quarterly earnings increased 6.1% from the year-ago quarter’s $1.47 per share.

Amdocs reported revenues of $1.25 billion, which came in line with the Zacks Consensus Estimate, as well as matched the midpoint of management’s guidance of $1.23-$1.27 billion. Compared with the year-ago quarter, revenues were up 1.8% on a reported basis and 2% on a constant-currency basis.

Amdocs Limited Price, Consensus and EPS Surprise Amdocs Limited Price, Consensus and EPS Surprise

Amdocs Limited price-consensus-eps-surprise-chart | Amdocs Limited Quote

Quarterly Details

Amdocs’ top-line performance was primarily driven by healthy growth in Europe and Rest of the World, offset by a decline in North America.

North America reported revenues of $823.2 million (66% of total revenues), which declined 0.7% year over year. Europe revenues (14.8% of total revenues) of $184.8 million increased 7.6% year over year. Rest of the World revenues (19% of total revenues) grew 6.8% year over year to $237.8 million. Our model estimates for North America, Europe and Rest of the World were pegged at $843.4 million, $181.2 million and $227.4 million, up 1.7%, 5.5% and 2.2%, respectively, year over year.

Managed services revenues rose 0.2% year over year to $720.3 million. The company ended the second quarter of fiscal 2024 with a 12-month backlog of $4.23 billion, up $20 million sequentially and $120 million year over year. Our model estimates for managed services revenues and backlog were pegged at $728.7 million and $4.20 billion, respectively.

The non-GAAP operating income increased 5.4% year over year to $229 million, while the operating margin expanded 60 basis points to 18.4%. The year-over-year improvement in the non-GAAP operating margin was mainly driven by the company’s continuous focus on improving operational excellence and the adoption of automation and artificial intelligence.

Balance Sheet and Cash Flow

Amdocs had cash and short-term investments of $544.4 million as of Mar 31, 2024 compared with $601 million as of Dec 31, 2023.

In the second quarter of fiscal 2024, net cash provided by operating activities was $132.7 million, down from $182.4 million in the previous quarter and $294.5 million in the year-ago period. Free cash flow was $113 million compared with the previous quarter’s $138.6 million and the year-earlier quarter’s $259.4 million.

The company repurchased shares worth $115 million in the second quarter of fiscal 2024.

Amdocs paid out $101 million in dividends and repurchased stocks worth $274 million during the second quarter of fiscal 2024. On May 8, the company’s board approved the next quarterly cash dividend of 47.9 cents. The increased quarterly cash dividend will be first paid on Jul 26 to shareholders of record as of Jun 28, 2024.

FY24 Guidance

For fiscal 2024, the company revised the revenue growth guidance from 1.1-5.1% to 1.6-3.6% on a reported basis. On a constant-currency basis, revenues are now projected to increase in the range of 1.7-3.7%.

For fiscal 2024, the company has lowered the GAAP diluted earnings per share guidance from 13-19.5% to 7.0-13.0%. The non-GAAP earnings per share is estimated to grow in the band of 7.0 -11.0 %.

The fiscal 2024 outlook reflects an expected unfavorable foreign currency impact of approximately 0.1% on a year-over-year basis. For fiscal 2024, the non-GAAP operating margin is expected in a range of 18.1-18.7%, the non-GAAP effective tax rate is anticipated in the band of 13-17% and free cash flow is projected at $700 million.

For the third quarter of fiscal 2024, the company projects revenues between $1.235 billion and $1.275 billion and adjusted earnings in the range of $1.57-$1.63 per share.

Zacks Rank and Stocks to Consider

Currently, Amdocs carries a Zacks Rank #3 (Hold). Shares of the company have lost 4.6% in the past year.

Some better-ranked stocks from the broader technology sector are NVIDIA NVDA, Arista Networks ANET and Salesforce CRM, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for NVDA’s 2025 earnings per share has been revised upward by 10 cents to $23.94 in the past 30 days. Shares of NVDA have surged 216.1% in the past year.

The Zacks Consensus Estimate for ANET’s 2024 earnings per share has been revised upward by 3 cents to $7.49 in the past 30 days. Shares of ANET have rallied 101.9% in the past year.

The Zacks Consensus Estimate for CRM’s 2024 earnings per share has been revised upward by 3 cents to $9.71 in the past 60 days. Shares of CRM have climbed 39.3% in the past year.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Salesforce Inc. (CRM) : Free Stock Analysis Report

Amdocs Limited (DOX) : Free Stock Analysis Report

NVIDIA Corporation (NVDA) : Free Stock Analysis Report

Arista Networks, Inc. (ANET) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.